Your browser doesn't support javascript.
loading
Comprehensive radiation shield minimizes operator radiation exposure in coronary and structural heart procedures.
Rizik, David G; Gosselin, Kevin P; Burke, Robert F; Goldstein, James A.
Afiliación
  • Rizik DG; Honor Health, Scottsdale, AZ, United States of America. Electronic address: DavidRizik@aol.com.
  • Gosselin KP; University of Texas at Tyler, AriTex LLC, Tyler, TX, United States of America.
  • Burke RF; Honor Health, Scottsdale, AZ, United States of America.
  • Goldstein JA; William Beaumont, Royal Oak, MI, United States of America.
Cardiovasc Revasc Med ; 64: 70-75, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38538447
ABSTRACT

OBJECTIVES:

This study evaluated the efficacy of a novel comprehensive shield designed to minimize radiation exposure (RE) to Physicians performing coronary and structural heart procedures.

BACKGROUND:

The Protego™ radiation shielding system (Image Diagnostics Inc., Fitchburg, Ma) is designed to provide comprehensive protection from RE and has been State certified sufficient to allow operators to perform procedures without orthopedically burdensome lead aprons.

METHODS:

This single center two-group cohort study assessed the efficacy of this shield in a large number of cardiac procedures (coronary and structural), comparing operator RE compared to standard protection methods (personal lead apparel and "drop down" shield).

RESULTS:

The Protego™ system reduced operator RE by 99 % compared to Standard Protection. RE was significantly lower at both "Head" level by thyroid median dose 0.0 (0.0, 0,0) vs 5.7 (2.9, 8.2) µSv (p < 0.001), as well as waist dose 0.0 (0.0, 0.0) vs 10.0 (5.0, 16.6) µSv (p < 0.001). "Zero" Total RE was documented by Raysafe™ in 64 % (n = 32) of TAVR cases and 73.2 % (n = 183) of the coronary cases utilizing Protego™. In contrast, standard protection did not achieve "Zero" exposure in a single case. These dramatic differences in RE were achieved despite higher fluoroscopy times in the Protego™ arm (11.9 ± 8.6 vs 14.3 ± 12.5 min, p = 0.015). Per case procedural exposure measured by Dose Area Product was higher in the Protego™ group compared to standard protection (115.4 ± 139.2 vs 74.9 ± 69.3, p < 0.001).

CONCLUSION:

The Protego™ shield provides total body RE protection for operators performing both coronary and structural heart procedures. This shield allows procedural performance without the need for personal lead aprons and has potential to reduce catheterization laboratory occupational health hazards.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dosis de Radiación / Protección Radiológica / Radiografía Intervencional / Exposición Profesional / Salud Laboral / Exposición a la Radiación Límite: Female / Humans / Male Idioma: En Revista: Cardiovasc Revasc Med Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dosis de Radiación / Protección Radiológica / Radiografía Intervencional / Exposición Profesional / Salud Laboral / Exposición a la Radiación Límite: Female / Humans / Male Idioma: En Revista: Cardiovasc Revasc Med Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos